RICOVR has developed a biosensor technology for rapid point-of-care testing. Company’s non-invasive portable testing devices will benefit employers and law .Patented technology is extremely sensitive and can quantitatively detect biomarkers even present in low quantity. Company is currently developing tests for THC and COVID. Platform has potential to add accurate and quantitative testing for other drugs-of-abuse and infectious diseases.